Golfers raising $$$ from the links to the lab. Enabling researchers with a great idea to prove their concept in the lab @ The James Cancer Hospital #GIVE18
Thanks to all of the teams who participated in our St. Charles Invitational today. We also raised just over $1,200 for @Give18_4Cancer fore cancer research. https://t.co/wjPjWzsEIL
But the minority of cancer patients who have been shown to respond to these drugs experience remissions measured not in extra weeks or months of life, but in lifetimes
Part 2 of 2
Right now, there are only handful of immunotherapies available. The majority of patients respond partially or not at all & some even develop & acquire resistance to the disease. Part 1 of 2
Wishing for more advancements through cancer research this holiday season. With your generosity we will continue to fund breakthroughs. Thank you & Merry Christmas from all of us @Give18_4Cancer
Cancer will replace heart disease as the leading cause of death in the United States within two years, according to US Centers for Disease Control and Prevention projections
ONE dollar for every hole once a year. Pretty simple & if every golfer did this we would have an incredible impact on a disease that touches all of us.
Please give today
https://t.co/9UqvqR5vZ0
#GivingTuesday
Are you a golfer?
Do you know someone touched by cancer?
We need your support!
GIVE18 funds critical cancer research using golf as a vehicle
https://t.co/9UqvqR5vZ0
#GivingTuesday
Any activities that get you moving and breathing a little harder count toward your daily 20-30 minutes of moderate exercise that can help lower your cancer risk #HealthyLife
The European Society for Medical Oncology recently announced the first modest immunotherapy success against triple negative breast cancer, a horribly aggressive disease found primarily in younger women, which has stubbornly resisted previous treatment options
There are reportedly 940 “new” cancer immunotherapeutic drugs being tested in the clinic by more than half-a-million cancer patients in more than 3,000 clinical trials, with over 1,000 more in the preclinical phase #CancerResearch